School of Public Health and Social Sciences, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, United Republic of Tanzania
Department of Public Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, United Republic of Tanzania.
BMJ Open. 2024 Jun 18;14(6):e080434. doi: 10.1136/bmjopen-2023-080434.
Aimed at determining facilitators and barriers to optimum uptake of multimonth dispensing (MMD) of antiretroviral treatment (ART).
Qualitative study conducted through in-depth interviews.
An explorative qualitative approach conducted at three high-volume care and treatment clinics in Morogoro Municipality, Tanzania.
Data were collected from a purposefully selected sample of 22 participants. Of them, 9 were healthcare providers and 12 were clients on ART receiving MMD. Audio records from the interviews were transcribed, translated, and thematically analysed.
Evidence showed that multimonth dispensing can be improved through strengthened health system barriers such as having proper guidelines and involving stakeholders. Other facilitators included service providers' ability to identify eligible clients, fast-tracking of services, quality improvement implementation, peer-to-peer inspiration and clients' satisfaction and awareness. Identified barriers to effective multimonth dispensing included inadequate drug supply, prolonged turn-around time of HIV viral load results, delayed integrated Tuberculosis (TB) preventive therapy initiation, stigma and retention challenges.
Multimonth dispensing has the potential to address the health system challenges in Tanzania if guidelines are well informed to stakeholders, and facets of quality of care are improved. Addressing the earmarked barriers such as ensuring medicine, supplies and diagnostics, while addressing retention challenges and stigma.
旨在确定促进和阻碍抗逆转录病毒治疗(ART)多剂量配药(MMD)最佳应用的因素。
通过深入访谈进行的定性研究。
在坦桑尼亚莫罗戈罗市的三个大容量护理和治疗诊所进行探索性定性方法。
从 22 名参与者中,通过有针对性的选择收集数据。其中,9 名是医疗保健提供者,12 名是接受 MMD 的接受 ART 的患者。采访的音频记录被转录、翻译,并进行主题分析。
证据表明,通过加强卫生系统障碍,如制定适当的指南和涉及利益相关者,可以改善多剂量配药。其他促进因素包括服务提供者识别合格患者的能力、服务的快速跟进、质量改进的实施、同伴激励以及患者的满意度和意识。有效多剂量配药的障碍包括药物供应不足、艾滋病毒病毒载量结果的周转时间延长、整合的结核病(TB)预防性治疗启动延迟、污名化和保留挑战。
如果向利益相关者充分告知指南,并改善护理质量的各个方面,多剂量配药有可能解决坦桑尼亚卫生系统面临的挑战。解决指定的障碍,如确保药物、供应品和诊断,同时解决保留挑战和污名化。